These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28626480)

  • 21. Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy.
    Satari N; Taymouri S; Varshosaz J; Rostami M; Mirian M
    Drug Dev Ind Pharm; 2020 Aug; 46(8):1265-1277. PubMed ID: 32594775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PLGA Ethionamide Nanoparticles for Pulmonary Delivery: Development and in vivo evaluation of dry powder inhaler.
    Debnath SK; Saisivam S; Omri A
    J Pharm Biomed Anal; 2017 Oct; 145():854-859. PubMed ID: 28826144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dry powder pulmonary delivery of cationic PGA-co-PDL nanoparticles with surface adsorbed model protein.
    Kunda NK; Alfagih IM; Dennison SR; Somavarapu S; Merchant Z; Hutcheon GA; Saleem IY
    Int J Pharm; 2015 Aug; 492(1-2):213-22. PubMed ID: 26169146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
    Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Spray-Dried Formulation of Peptide-DNA Nanoparticles into a Dry Powder for Pulmonary Delivery Using Factorial Design.
    Munir M; Kett VL; Dunne NJ; McCarthy HO
    Pharm Res; 2022 Jun; 39(6):1215-1232. PubMed ID: 35441318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H; Teo J; Chew JW; Hadinoto K
    Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity.
    Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.
    Ezzati Nazhad Dolatabadi J; Hamishehkar H; Valizadeh H
    Drug Dev Ind Pharm; 2015; 41(9):1431-7. PubMed ID: 25220930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection.
    Arora S; Haghi M; Loo CY; Traini D; Young PM; Jain S
    Mol Pharm; 2015 Jun; 12(6):2001-9. PubMed ID: 25923171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies.
    Alhowyan AA; Altamimi MA; Kalam MA; Khan AA; Badran M; Binkhathlan Z; Alkholief M; Alshamsan A
    J Microbiol Methods; 2019 Jun; 161():87-95. PubMed ID: 30738109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis.
    Vishwa B; Moin A; Gowda DV; Rizvi SMD; Hegazy WAH; Abu Lila AS; Khafagy ES; Allam AN
    Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33430162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dry powder formulation of azithromycin for COVID-19 therapeutics.
    Chan SHY; Sheikh K; Zariwala MG; Somavarapu S
    J Microencapsul; 2023 Jun; 40(4):217-232. PubMed ID: 36752024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles.
    Yang M; Yamamoto H; Kurashima H; Takeuchi H; Yokoyama T; Tsujimoto H; Kawashima Y
    Eur J Pharm Sci; 2012 Aug; 47(1):235-43. PubMed ID: 22683651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradermal Vaccination with PLGA Nanoparticles via Dissolving Microneedles and Classical Injection Needles.
    Lee J; Neustrup MA; Slütter B; O'Mahony C; Bouwstra JA; van der Maaden K
    Pharm Res; 2024 Feb; 41(2):305-319. PubMed ID: 38332390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A quality-by-design strategic approach for the development of bedaquiline-pretomanid nanoparticles as inhalable dry powders for TB treatment.
    Patil SM; Diorio AM; Kommarajula P; Kunda NK
    Int J Pharm; 2024 Mar; 653():123920. PubMed ID: 38387819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility study of aerosolized prostaglandin E1 microspheres as a noninvasive therapy for pulmonary arterial hypertension.
    Gupta V; Rawat A; Ahsan F
    J Pharm Sci; 2010 Apr; 99(4):1774-89. PubMed ID: 19894275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of ciprofloxacin-loaded nano-and microcomposite particles for dry powder inhaler formulations: preparation, in vitro characterisation, and antimicrobial efficacy.
    Topal GR; Devrim B; Eryilmaz M; Bozkir A
    J Microencapsul; 2018 Sep; 35(6):533-547. PubMed ID: 30213209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.